MedTrace Logo

Multimodal Intervention for GGT Reduction in Alcohol Use Disorder (GGT-AUD)

NCT07603726 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 197

Last updated 2026-05-22

No results posted yet for this study

Summary

The aim of this clinical trial is to evaluate whether a combined nutraceutical and psychological intervention can reduce gamma-glutamyl transferase (GGT) levels in individuals with Alcohol Use Disorder (AUD).

The main question it seeks to answer is:

• Does this combined intervention lead to a reduction in GGT levels over time? Participants with Alcohol Use Disorder and elevated GGT levels were included in the study.

Participants will:

* Receive nutraceutical supplements aimed at supporting liver function
* Participate in psychological support sessions to help reduce alcohol consumption
* Have their GGT levels monitored over time.

Conditions

  • Alcohol Use Disorder (AUD)

Interventions

BEHAVIORAL

Alcohol Reduction Counseling

Participants received structured counseling focused on reducing alcohol consumption and improving lifestyle behaviors. The intervention included educational guidance and recommendations regarding alcohol use and general health.

DIETARY_SUPPLEMENT

Nutraceutical Treatment

Participants received nutraceutical supplementation aimed at supporting liver function and reducing alcohol-related liver stress. The intervention included compounds commonly used for hepatoprotective support.

BEHAVIORAL

Psychological Intervention

Participants received structured psychological support designed to reduce alcohol consumption and improve adherence to behavioral recommendations.

Sponsors & Collaborators

  • Medical Center TOPMED

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2026-04-01
Completion
2026-04-01

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07603726 on ClinicalTrials.gov